X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
IPCA Labs Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA Labs Quarterly Results   (IPLB)

Here are the latest quarterly results of IPCA Labs. For more details, see the IPCA Labs financial fact sheet and IPCA Labs share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

IPCA Labs Quarterly Results

No. of Mths
Qtr. Ending
3
Sep-16
3
Dec-16
3
Mar-17
*
3
Jun-17
3
Sep-17
3
Dec-17
3
Mar-18
3
Jun-18
8-Qtr Chart
Click to enlarge
Net Sales Rs m8,8517,5076,6587,1308,6438,5927,8288,539 
Other income Rs m62595262110110114136 
Turnover Rs m8,9137,5676,7107,1918,7538,7027,9418,676 
Expenses Rs m7,4926,4435,9816,9147,1536,9806,7297,399 
Gross profit Rs m1,3581,0656772151,4901,6121,0991,140 
Depreciation Rs m429432428433441438432445 
Interest Rs m6857445664566549 
Profit before tax Rs m924636257-2121,0961,228717782 
Tax Rs m374222-187-10131172204127 
Profit after tax Rs m550414444-2039651,056513655 
Gross profit margin %15.314.210.23.017.218.814.013.4 
Effective tax rate %40.534.9-72.74.612.014.028.416.2 
Net profit margin %6.25.56.7-2.811.212.36.67.7 
Diluted EPS Rs 4.4 3.3 3.5 -1.6 7.6 8.4 4.1 5.2  
Diluted EPS (TTM) Rs 10.5 11.9 14.9 9.5 12.8 17.9 18.5 25.3  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: IPCA Labs 1QFY19 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   GSK PHARMA  FRESENIUS KABI ONCO.  ASTRAZENECA PHARMA  NATCO PHARMA  FDC LTD.  

Compare IPCA LABS With:   GSK PHARMA  FRESENIUS KABI ONCO.  ASTRAZENECA PHARMA  NATCO PHARMA  FDC LTD.  

Compare IPCA LABS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices End Volatile Day in Red; Energy Stocks Drag(Closing)

After opening the day in green, share markets in India witnessed volatile trading activity throughout the day and ended the day in red.

Views on news

IPCA LABS Announces Quarterly Results (1QFY19); Net Profit Down 423.6% (Quarterly Result Update)

Aug 13, 2018 | Updated on Aug 13, 2018

For the quarter ended June 2018, IPCA LABS has posted a net profit of Rs 655 m (down 423.6% YoY). Sales on the other hand came in at Rs 9 bn (up 19.8% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

IPCA LABS Announces Quarterly Results (4QFY18); Net Profit Up 15.6% (Quarterly Result Update)

May 30, 2018 | Updated on May 30, 2018

For the quarter ended March 2018, IPCA LABS has posted a net profit of Rs 513 m (up 15.6% YoY). Sales on the other hand came in at Rs 8 bn (up 17.6% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

You Can Buy Select Auto Stocks Now for Big Long-Term Returns(The 5 Minute Wrapup)

Oct 17, 2018

Irrespective of the earnings hiccups, these businesses be setting new profit records.

Here's What You Should Do In this Market...(Profit Hunter)

Oct 9, 2018

Sticking to a process and discipline is the only way to survive and thrive in the market downcycles.

IPO Market Feels the Heat of the Market Crash(Sector Info)

Oct 12, 2018

The sentiments in primary market have also deteriorated amid the stock market correction. Most listed IPOs of 2018 are trading below their issue price.

Even If IL&FS Group Brought This Correction, this is Right Time to Buy & Sit Tight!(Chart Of The Day)

Oct 12, 2018

Even if IL&FS is the culprit, it may turn out to be a hero if you buy right and sit tight.

A Portfolio Strategy That Could Help You Reduce Shocks Of The Equity Market(Outside View)

Oct 9, 2018

PersonalFN explains a portfolio strategy that could help you reduce the shocks of the Indian equity market.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

IPCA LABS SHARE PRICE


Oct 22, 2018 (Close)

TRACK IPCA LABS

  • Track your investment in IPCA LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON IPCA LABS

IPCA LABS - ABBOTT INDIA COMPARISON

COMPARE IPCA LABS WITH

MARKET STATS